News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Harvard Bioscience Inc. (HBIO) Drops IPO, Plans to Spin Off HART Subsidiary Instead



10/21/2013 8:14:14 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Harvard Bioscience won't go IPO with its regenerative organ transplant device subsidiary, Harvard Apparatus Regenerative Technology Inc. (HART). Instead it will spin off HART as a newly public company, effective Nov. 1. According to Harvard Bioscience president David Green, the spin-off will enable Holliston, Mass.-based Harvard Bioscience to renew a growth-by-acquisition strategy it has pursued over the past 17 years.

Help employers find you! Check out all the jobs and post your resume.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES